Clinical application of combined detection of HE4 and CA125 in patients with endometriosis
10.3969/j.issn.1673-4130.2015.14.054
- VernacularTitle:H E4与CA125联合检测在子宫内膜异位症患者的临床应用
- Author:
Na LUO
;
Xinghua HUANG
;
Xingrong ZHONG
;
Wanting ZHONG
;
Xiaoming GUAN
- Publication Type:Journal Article
- Keywords:
endometriosis;
epididymis protein 4;
cancer antigen 125
- From:
International Journal of Laboratory Medicine
2015;(14):2075-2076
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the application value of single or combined detection of HE4 and CA125 in the differentia‐tion diagnosis of endometriosis .Methods The detection results of serum HE4 and CA125 levels in 105 cases of patients with ovari‐an endometriosis (endometriosis group) ,53 cases of patients with (ovarian malignant group) tumor and 64 healthy women undergo‐ing the healthy physical examination(control group) were performed the retrospective and statistical analysis .Results The positive rates of serum HE4 in the endometriosis group ,ovarian malignant tumor group and control group were 57 .1% ,90 .6% and 12 .5%respectively with statistically significant difference among them (P< 0 .05) .The positive rates of serum CA125 in the above 3 groups were 44 .8% ,92 .5% and 14 .0% respectively ,and the differences were statistically significant(P<0 .05) .(3)The sensitivity and specificity of 70 pmol/L≤ HE4<150 pmol/L for diagnosing endometriosis were 57 .14% and 53 .86% respectively ,which of 35 U/mL≤CA125<150 U/mL for diagnosing endometriosis were 44 .76% and 61 .24% .But the sensitivity and specificity of their combined detection were 70 .32% and 60 .38% .There were statistically significant differences of sensitivity and specificity among single and combined detecion of HE4 and CA125(P<0 .05) .Conclusion Serum HE4 and CA125 levels are significantly elevated in the patients with endometriosis ,their combined detection could further raise the sensitivity for diagnosing endometriosis .
